Terminology Service for NFDI4Health
All terms in BAO
| Label | Id | Description |
|---|---|---|
| cell surface | GO_0009986 | [The external part of the cell wall and/or plasma membrane.] |
| exact match structure search | BAO_0002259 | |
| random conformational search | BAO_0002251 | |
| cartesian conformational search | BAO_0002252 | |
| dihedral conformational search | BAO_0002253 | |
| systematic conformational search | BAO_0002254 | |
| database filtering | BAO_0002255 | |
| Lipinski rule of 5 filtering | BAO_0002256 | [Set of criteria for predicting the oral bioavailability of a compound on the basis of simple molecular features (molecular weight, CLogP, numbers of hydrogen- bond donors and acceptors).] |
| bladder adenocarcinoma | DOID_3711 | [A bladder carcinoma that derives_from epithelial cells of glandular origin.] |
| bladder carcinoma | DOID_4007 | [A urinary bladder cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.] |
| library design | BAO_0002257 | [Library design enables access to the large number of drug- like molecules that could theoretically be made and can serve several purposes: for example, to generate a maximally diverse virtual library for lead generation, a biased library aimed at a specific target or target family, or a lead optimization library.] |
| Mycoplasma genitalium metabolite | CHEBI_131604 | |
| bacterial metabolite | CHEBI_76969 | |
| ovarian carcinoma | DOID_4001 | |
| EC 3.5.1.4 (amidase) inhibitor | CHEBI_77941 | |
| EC 1.8.5.* (oxidoreductase acting on sulfur group donors, quinone or similar as acceptor) inhibitor | CHEBI_90920 | |
| EC 1.8.5.4 (sulfide:quinone reductase) inhibitor | CHEBI_90921 | |
| EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor | CHEBI_76617 | |
| EC 6.1.1.4 (leucine--tRNA ligase) inhibitor | CHEBI_77953 | |
| food firming agent | CHEBI_77960 |